Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TMEM50B Inhibitors

TMEM50B is a transmembrane protein that, while not thoroughly characterized, is understood to play a role in various cellular processes. The gene's expression and the activity of the protein may be central to the function of certain cellular pathways. As with many proteins, the expression of TMEM50B can be influenced by a multitude of factors, including cellular signals and environmental stressors. In the quest to understand TMEM50B's function and regulation, researchers have turned their attention to chemical compounds that could potentially serve as inhibitors, reducing or silencing the expression of TMEM50B. Such chemical inhibitors are tools for research to dissect the biological role of TMEM50B. The interaction between these compounds and TMEM50B expression provides valuable insights into the protein's regulatory mechanisms and its place within the cellular framework.

Among the compounds that could inhibit TMEM50B expression are various molecules that interfere with gene expression at the transcriptional or post-transcriptional level. For instance, 5-Azacytidine and Decitabine are inhibitors that might reduce TMEM50B expression through the inhibition of DNA methylation, altering the chromatin state surrounding the TMEM50B gene and thus its transcriptional activity. Compounds like Mithramycin A, which can bind to specific DNA sequences, could repress the transcription of the TMEM50B gene by preventing transcription factor access. On the other hand, histone deacetylase (HDAC) inhibitors such as Sodium Butyrate and Vorinostat might lead to changes in chromatin structure around the TMEM50B gene, causing a reduction in its expression. Inhibitors like Genistein and LY294002 operate at the signaling level, potentially leading to a decrease in TMEM50B expression by disrupting phosphorylation-dependent signaling cascades that control gene expression. It is important to note, these interactions are speculative and are based on the known actions of these chemicals on cellular mechanisms broadly, not on TMEM50B specifically. Rigorous scientific research is necessary to determine the validity of these interactions and to uncover the precise role and regulation of TMEM50B within the cell.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Might cause DNA demethylation at the TMEM50B gene locus, leading to a decrease in its transcriptional activity.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Could bind specifically to GC-rich DNA sequences in the TMEM50B promoter region, resulting in transcriptional repression of this gene.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

As an HDAC inhibitor, sodium butyrate may promote histone acetylation, potentially leading to the downregulation of TMEM50B expression through chromatin remodeling.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

May inhibit histone deacetylase activity, causing an increase in acetylated histones and a subsequent decrease in TMEM50B mRNA synthesis.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Could activate retinoic acid receptors that repress the transcriptional activity of the TMEM50B gene.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

As a tyrosine kinase inhibitor, genistein could disrupt specific phosphorylation-dependent signaling cascades, resulting in the decreased expression of TMEM50B.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

By inhibiting mTOR, Rapamycin might lead to a reduction in cap-dependent translation, thereby decreasing the levels of proteins including TMEM50B.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Could inhibit PI3K, leading to the attenuation of AKT phosphorylation and a subsequent reduction in the transcriptional levels of TMEM50B.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

May directly inhibit the transcription machinery, leading to the decreased synthesis of TMEM50B mRNA.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

This DNA methyltransferase inhibitor might lead to the hypomethylation of the TMEM50B gene, resulting in reduced expression.